Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance

ABSTRACT COVID-19 is a complex disease involving immunological, vascular, and metabolic pathology caused by and consequences of beta-coronavirus SARS-CoV-2 infection. One may use Sun Tzu analogy of war to fight COVID-19 and to survive infection. When enemy has not reached the shore, gathering much...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Ahmad Utomo
Formato:	article
Lenguaje:	EN
Publicado:	Diponegoro University 2020
Materias:	covid-19 sars-cov-2 inflammation coagulation diagnostic Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/4daf8c6b935d46faa4299d014c00c678
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4daf8c6b935d46faa4299d014c00c678
record_format	dspace
spelling	oai:doaj.org-article:4daf8c6b935d46faa4299d014c00c6782021-11-05T16:47:42ZKnowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance2503-217810.14710/jbtr.v6i2.8472https://doaj.org/article/4daf8c6b935d46faa4299d014c00c6782020-08-01T00:00:00Zhttps://ejournal2.undip.ac.id/index.php/jbtr/article/view/8472https://doaj.org/toc/2503-2178ABSTRACT COVID-19 is a complex disease involving immunological, vascular, and metabolic pathology caused by and consequences of beta-coronavirus SARS-CoV-2 infection. One may use Sun Tzu analogy of war to fight COVID-19 and to survive infection. When enemy has not reached the shore, gathering much intelligence is key to know how the enemy moves and who would be the most vulnerable targets of enemy attacks. Physical distancing, massive nucleic acid testing, and identification of comorbidity may prepare for the incoming enemies. Physical distancing has helped to limit transmission of the virus that mainly due to close contacts with droplets coughed off infected individuals. Moreover, aerosolized virus particles may also contribute to spreading. Nucleic acid testing using real time PCR platform has been a diagnostic gold standard to identify infected individuals during early stage of infection. On the other hand, serological test to capture antibody against SARS-CoV-2 may be useful for immunosurveillance. Discovery of human ACE2 (angiotensin converting enzyme) protein as an obligate partner of SARS-CoV-2 viral entry has provided insights to mechanisms of serious post-infection ramifications to individuals having comorbidities such as hypertension, diabetes or heart conditions. When the enemy reaches ashore, thorough profiling of biomarkers involved in inflammation and coagulation (IL-6, lymphopenia, ground glass opacity, d-dimers, thrombocytopenia) may help predict disease progression and guide treatment strategy. While estimated 80% of infected individuals may recover on their own, the remaining 20% may require hospitalization and serious therapeutic intervention. Several clinical trials are underway such as repurposing existing drugs and evaluating efficacy of convalescence plasma therapy. Finally, vaccine development using genetic engineering may also help control the global spread if it is proven effective.Ahmad UtomoDiponegoro Universityarticlecovid-19sars-cov-2inflammationcoagulationdiagnosticMedicine (General)R5-920ENJournal of Biomedicine and Translational Research, Vol 6, Iss 2, Pp 63-73 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	covid-19 sars-cov-2 inflammation coagulation diagnostic Medicine (General) R5-920
spellingShingle	covid-19 sars-cov-2 inflammation coagulation diagnostic Medicine (General) R5-920 Ahmad Utomo Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance
description	ABSTRACT COVID-19 is a complex disease involving immunological, vascular, and metabolic pathology caused by and consequences of beta-coronavirus SARS-CoV-2 infection. One may use Sun Tzu analogy of war to fight COVID-19 and to survive infection. When enemy has not reached the shore, gathering much intelligence is key to know how the enemy moves and who would be the most vulnerable targets of enemy attacks. Physical distancing, massive nucleic acid testing, and identification of comorbidity may prepare for the incoming enemies. Physical distancing has helped to limit transmission of the virus that mainly due to close contacts with droplets coughed off infected individuals. Moreover, aerosolized virus particles may also contribute to spreading. Nucleic acid testing using real time PCR platform has been a diagnostic gold standard to identify infected individuals during early stage of infection. On the other hand, serological test to capture antibody against SARS-CoV-2 may be useful for immunosurveillance. Discovery of human ACE2 (angiotensin converting enzyme) protein as an obligate partner of SARS-CoV-2 viral entry has provided insights to mechanisms of serious post-infection ramifications to individuals having comorbidities such as hypertension, diabetes or heart conditions. When the enemy reaches ashore, thorough profiling of biomarkers involved in inflammation and coagulation (IL-6, lymphopenia, ground glass opacity, d-dimers, thrombocytopenia) may help predict disease progression and guide treatment strategy. While estimated 80% of infected individuals may recover on their own, the remaining 20% may require hospitalization and serious therapeutic intervention. Several clinical trials are underway such as repurposing existing drugs and evaluating efficacy of convalescence plasma therapy. Finally, vaccine development using genetic engineering may also help control the global spread if it is proven effective.
format	article
author	Ahmad Utomo
author_facet	Ahmad Utomo
author_sort	Ahmad Utomo
title	Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance
title_short	Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance
title_full	Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance
title_fullStr	Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance
title_full_unstemmed	Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance
title_sort	knowing when and how to fight: covid-19 between viral clearance and immune tolerance
publisher	Diponegoro University
publishDate	2020
url	https://doaj.org/article/4daf8c6b935d46faa4299d014c00c678
work_keys_str_mv	AT ahmadutomo knowingwhenandhowtofightcovid19betweenviralclearanceandimmunetolerance
_version_	1718444100656562176

Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance

Ejemplares similares